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Abstract
Cutis laxa is a connective tissue disorder with distinctive lax, redundant, and inelastic skin. It is a 
genetically heterogenous disorder with autosomal dominant and recessive patterns of inheritance. 
We report a patient with cutis laxa supported by clinical, microscopic, and ultrastructural findings. 
Molecular analysis of fibulin-4 and -5, of the α2 subunit of the V-type H+ ATPase, and of the 
component of the oligomeric Golgi complex 7 (COG7) genes excluded the type I and type II 
autosomal recessive forms of cutis laxa, and congenital disorders of glycosylation associated with 
cutis laxa. Remarkably, our patient also presented severe and lethal pulmonary hypertension as a 
newborn. This case with cutis laxa, severe pulmonary hypertension, and no detectable mutations 
in fibulin-4 and -5 genes may represent a previously unrecognized syndrome.
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Introduction
Cutis laxa (CL) is a rare connective tissue disorder characterized by lax, redundant, and 
inelastic skin. CL is a genetically heterogenous condition including the autosomal dominant 
(ADCL; OMIM 123700) and autosomal recessive (ARCL types I and II; OMIM 219100 and 
219200, respectively) forms. The autosomal dominant form is caused by mutations in the 
elastin (ELN) gene and presents with additional manifestations such as gastrointestinal 
diverticula, hernias, uterine prolapse, pulmonary artery stenosis, aortic and arterial dilatation 
and tortuosity, Raynaud's phenomenon, bronchiectasis, and emphysema (Szabo et al. 2006; 
Urban et al. 2005). Homozygous mutations in ELN have been recently reported in autosomal 
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recessive CL (Megarbane et al. 2009). The autosomal recessive forms are clinically more 
severe and are often accompanied by pulmonary emphysema and cardiovascular 
complications, which can lead to death in childhood. ARCL type I is a specific, life-
threatening disorder with organ involvement, lung atelectasis and emphysema, diverticulae 
of the gastrointestinal and genitourinary system, and vascular anomalies (arterial aneurysms, 
fibromuscular artery dysplasia and stenoses, including peripheral pulmonary stenoses). 
Although mutations have been detected in the fibulin-5 (FBLN5) and the fibulin-4 (FBLN4) 
genes in a few children with the severe forms of cutis laxa syndrome (Dasouki et al. 2007; 
Hucthagowder et al. 2006; Loeys et al. 2002), the underlying genetic etiology in the 
majority of cases is still unknown. ARCL type II is associated with joint laxity, 
developmental delay, pre- and post-natal growth delay, large fontanels with delayed closure, 
and congenital hip dislocation. Congenital disorder of glycosylation type IIe owing to a 
defect in conserved oligomeric Golgi complex 7 (COG7) is responsible for a form of cutis 
laxa associated with pulmonary hypertension, growth retardation, severe microcephaly, 
hypotonia, adducted thumbs, feeding problems due to gastrointestinal pseudo-obstruction, 
failure to thrive, cardiac anomalies, and episodes of extreme hyperthermia (Morava et al. 
2007; Wu et al. 2004). Moreover, recessive mutations in the LTPB4 have recently been 
associated with a cutis laxa syndrome with impaired pulmonary, gastrointestinal, 
genitourinary and muskoloskeletal development (Urban et al. 2009). In addition, impaired 
glycosylation caused by mutations of the α2 subunit of the V-type H+ ATPase and 
mutations in the pyrroline-5-carboxylate reductase 1 gene have been described in several 
families with ARCL type II (Guernsey et al. 2009; Hucthagowder et al. 2009; Kornak et al. 
2008).
Case report
We report a male born by a spontaneous vaginal delivery after 37 weeks of gestation 
complicated by oligohydramnios detected a week before delivery and intrauterine growth 
retardation (IUGR). The parents both from South America had a previous miscarriage and 
were not consanguineous. The family history was otherwise unremarkable. Apgar scores 
were 8 at one minute and 9 at five minutes. At birth, weight was 1755 grams (below the 3rd 
centile), length 46 cm (25th centile), and head circumference 30.5 cm (10th centile). Shortly 
after birth, the patient developed respiratory distress which worsened progressively during 
the first hours of life requiring oxygen treatment. An echocardiogram revealed pulmonary 
hypertension. From the second day of life he was maintained on oxygen and inhaled nitric 
oxide by nasal cannula. On the sixth day of life the patient exhibited a significant worsening 
of the respiratory distress and of the metabolic acidosis. He was intubated, placed on 100% 
oxygen and inhaled nitric oxide at 20 PPM. However, despite the aggressive treatment, the 
patient had escalating pulmonary pressures as measured by echocardiogram. From birth he 
was also noted to have skin laxity. The patient’s physical examination was also remarkable 
for the presence of blue sclerae, redundant skin on the nasal bridge, low-set right ear, and 
hooked nose. The skin was transparent with prominent venous pattern and redundant with 
reduced elastic recoil (Figure 1A and B). He also exhibited umbilical hernia and bilateral 
cryptorchidism. Upong percutaneous phlebotomy the patient's skin and deep tissues were 
noted to be fibrous and the veins were abnormally fragile blood. Over time, the patient 
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became more difficult to oxygenate despite maximal ventilator settings and attempts to start 
the patient on high frequency oscillation were unsuccessful. The chest x-ray revealed a right 
lower lobe infiltrate consistent with pneumonia for which intravenous antibiotics were 
given. The patient also required pressor support to maintain adequate blood pressures. A 2D-
echocardiogram showed increased pulmonary pressures which measured above the systemic 
pressure values consistent with severe pulmonary hypertension. The clinical condition of the 
patient continued to worsen over the next few days with progressive rising in blood lactate. 
Following discussion with the medical team and parents, intervention was withdrawn on day 
of life 11. Permission for autopsy was obtained. Clinical laboratory investigations obtained 
prior to death revealed minimally elevated serum copper (101 µg/dl) and ceruloplasmin 
(28.7 mg/dl). Chromosome analysis (46,XY) and chromosomal microarray analysis 
(genome coverage of the microarray can be found at http://www.bcm.edu/geneticlabs/cma/
tables.html) were normal.
Methods
FBLN4, FBLN5, ATP6V0A2, COG7 molecular analyses
Mutational analysis of exons, intron/exon boundaries was performed on a genomic DNA 
sample of the patient by PCR and direct sequencing. Primers used for PCR amplification of 
FBLN4, FBLN5, ATP6V0A2, COG7 genes are available upon request.
Results
Pathological studies
Gross examination at autopsy revealed right ventricular hypertrophy, bilateral rib cartilage 
fusion between 10th–11th and 11th–12th ribs, and a normal appearance of the brain. The lung 
examination confirmed the presence of acute bronchopneumonia in the right middle lobe 
suspected on the chest X-ray. The lungs were congested with moderate to severe pulmonary 
arterial hypertensive changes and patchy parenchymal necrosis (Figure 2A and B). In 
addition, there was diffuse alveolar enlargement suggesting impaired lung growth and 
development. The severity of the pulmonary arteriopathy did not appear to be due to the 
alveolar enlargement alone. No microscopic abnormalities of the artery walls were detected. 
Histological examination of the skin showed an intact epidermis and a reduction in elastic 
fibers in papillary dermis and deep dermis (Figure 3). The hair appendages appeared normal. 
On ultrastructural examination elastic fiber fragmentation and increased granular substance 
were evident (Figure 4).
FBLN4, FBLN5, ATP6V0A2, COG7 molecular analyses
No mutations were found in the coding sequences of the FBLN4, FBLN5, ATP6V0A2, and 
COG7 genes (data not shown).
Discussion
We report a patient with a clinical diagnosis of CL supported by microscopic and 
ultrastructural findings. By laboratory studies, we ruled out the autosomal recessive forms of 
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CL type I due to FBLN4 and FBLN5 mutations, ARCL type II due to mutations of the α2 
subunit of the V-type H+ ATPase. Blood sample for transferrin isoelectric focusing (IEF) 
was not obtained in our patient; however, results of transferrin IEF has been reported to be 
normal up to the age of 4 months even if affected individuals who later have diagnostic 
values (Morava et al. 2009). Therefore, we performed direct sequencing of the COG7 gene 
to rule out the form of CL due to congenital disorder of glycosylation. Sequence analysis of 
this gene was negative for mutation.
A neonatal lethal case of CL with arterial wall thickening, aneurysmal dilation of the 
ascending aorta and dissection of the pulmonary artery wall due to compound heterozygous 
mutations in FBLN4 has been previously reported (Dasouki et al. 2007). Importantly, 
mutations of the coding regions of the FBLN4 have been excluded in the patient we report. 
Stenoses of the pulmonary artery or its branches have been previously reported in children 
with CL (Hayden et al. 1968; Pandey et al. 2008; Tsuji et al. 1990; Weir et al. 1977) but to 
our knowledge, neonatally lethal pulmonary hypertension has not been described in CL.
Neonatal pulmonary hypertension is a rare, fatal condition defined by a sustained increase in 
pulmonary vascular resistance after birth resulting is right-to-left shunting of blood through 
fetal circulatory pathways. Severe cases can lead to intractable hypoxemia that fails to 
respond to conventional respiratory support. This condition can be associated with a variety 
of respiratory conditions such as meconium aspiration, pneumonia, and respiratory distress 
syndrome. However, the etiology of neonatal pulmonary hypertension is often undetermined 
(Rubin, 1997). Bone morphogenetic protein receptor type II (BMPR-II), a member of the 
transforming growth factor- β (TGF-β) receptor family has been involved in the familial 
form of primary pulmonary hypertension (PPHN) which is inherited in an autosomal 
dominant fashion with low penetrance (Deng et al. 2000; Lane et al. 2000; Machado et al. 
2001; Thomson et al. 2000). Microscopically, PPHN is characterized by proliferation of 
pulmonary artery smooth muscle and endothelial cells, by intimal hyperplasia, and by in situ 
thrombus formation. All these features were also observed in our case (Figure 2B). We 
speculate that BPMR-II or other members of the TGF-β receptor family could be involved in 
our case because there are several experimental evidences linking genes involved in CL and 
those involved in PPHN. First, FBLN5 gene expression is regulated via TGF-β/Smad 
signaling (Kuang et al. 2006). Second latent TGF-β-binding protein 2 (LTBP-2) promote 
elastic fiber assembly by fibulin-5 (Hirai et al. 2007). Third, several cardiac and vascular 
abnormalities have been observed in fibulin-4 deficient mice (Hanada et al. 2007).
In summary, we report a patient with CL with associated neonatally lethal pulmonary 
hypertension which could represent a new form of CL. The description of additional cases 
with similar clinical presentation would help confirm and define the features of this newly 
recognized association.
Acknowledgments
We thank Don Singer for critical review of the manuscript. We are grateful to Prof Gert Mathijs for his support.
Brunetti-Pierri et al. Page 4










Dasouki M, Markova D, Garola R, Sasaki T, Charbonneau NL, Sakai LY, Chu ML. Compound 
heterozygous mutations in fibulin-4 causing neonatal lethal pulmonary artery occlusion, aortic 
aneurysm, arachnodactyly, and mild cutis laxa. Am J Med Genet A. 2007; 143A:2635–2641. 
[PubMed: 17937443] 
Deng Z, Morse JH, Slager SL, Cuervo N, Moore KJ, Venetos G, Kalachikov S, Cayanis E, Fischer SG, 
Barst RJ, Hodge SE, Knowles JA. Familial primary pulmonary hypertension (gene PPH1) is caused 
by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet. 2000; 67:737–
744. [PubMed: 10903931] 
Guernsey DL, Jiang H, Evans SC, Ferguson M, Matsuoka M, Nightingale M, Rideout AL, Provost S, 
Bedard K, Orr A, Dube MP, Ludman M, Samuels ME. Mutation in pyrroline-5-carboxylate 
reductase 1 gene in families with cutis laxa type 2. Am J Hum Genet. 2009; 85:120–129. [PubMed: 
19576563] 
Hanada K, Vermeij M, Garinis GA, de Waard MC, Kunen MG, Myers L, Maas A, Duncker DJ, 
Meijers C, Dietz HC, Kanaar R, Essers J. Perturbations of vascular homeostasis and aortic valve 
abnormalities in fibulin-4 deficient mice. Circ Res. 2007; 100:738–746. [PubMed: 17293478] 
Hayden JG, Talner NS, Klaus SN. Cutis laxa associated with pulmonary artery stenosis. J Pediatr. 
1968; 72:506–509. [PubMed: 5647293] 
Hirai M, Horiguchi M, Ohbayashi T, Kita T, Chien KR, Nakamura T. Latent TGF-beta-binding protein 
2 binds to DANCE/fibulin-5 and regulates elastic fiber assembly. Embo J. 2007; 26:3283–3295. 
[PubMed: 17581631] 
Hucthagowder V, Morava E, Kornak U, Lefeber DJ, Fischer B, Dimopoulou A, Aldinger A, Choi J, 
Davis EC, Abuelo DN, Adamowicz M, Al-Aama J, Basel-Vanagaite L, Fernandez B, Greally MT, 
Gillessen-Kaesbach G, Kayserili H, Lemyre E, Tekin M, Turkmen S, Tuysuz B, Yuksel-Konuk B, 
Mundlos S, Van Maldergem L, Wevers RA, Urban Z. Loss-of-function mutations in ATP6V0A2 
impair vesicular trafficking, tropoelastin secretion and cell survival. Hum Mol Genet. 2009; 
18:2149–2165. [PubMed: 19321599] 
Hucthagowder V, Sausgruber N, Kim KH, Angle B, Marmorstein LY, Urban Z. Fibulin-4: a novel 
gene for an autosomal recessive cutis laxa syndrome. Am J Hum Genet. 2006; 78:1075–1080. 
[PubMed: 16685658] 
Kornak U, Reynders E, Dimopoulou A, van Reeuwijk J, Fischer B, Rajab A, Budde B, Nurnberg P, 
Foulquier F, Lefeber D, Urban Z, Gruenewald S, Annaert W, Brunner HG, van Bokhoven H, 
Wevers R, Morava E, Matthijs G, Van Maldergem L, Mundlos S. Impaired glycosylation and cutis 
laxa caused by mutations in the vesicular H+-ATPase subunit ATP6V0A2. Nat Genet. 2008; 40:32–
34. [PubMed: 18157129] 
Kuang PP, Joyce-Brady M, Zhang XH, Jean JC, Goldstein RH. Fibulin-5 gene expression in human 
lung fibroblasts is regulated by TGF-beta and phosphatidylinositol 3-kinase activity. Am J Physiol 
Cell Physiol. 2006; 291:C1412–C1421. [PubMed: 16837650] 
Lane KB, Machado RD, Pauciulo MW, Thomson JR, Phillips JA 3rd, Loyd JE, Nichols WC, 
Trembath RC. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause 
familial primary pulmonary hypertension. The International PPH Consortium. Nat Genet. 2000; 
26:81–84. [PubMed: 10973254] 
Loeys B, Van Maldergem L, Mortier G, Coucke P, Gerniers S, Naeyaert JM, De Paepe A. 
Homozygosity for a missense mutation in fibulin-5 (FBLN5) results in a severe form of cutis laxa. 
Hum Mol Genet. 2002; 11:2113–2118. [PubMed: 12189163] 
Machado RD, Pauciulo MW, Thomson JR, Lane KB, Morgan NV, Wheeler L, Phillips JA 3rd, 
Newman J, Williams D, Galie N, Manes A, McNeil K, Yacoub M, Mikhail G, Rogers P, Corris P, 
Humbert M, Donnai D, Martensson G, Tranebjaerg L, Loyd JE, Trembath RC, Nichols WC. 
BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary 
hypertension. Am J Hum Genet. 2001; 68:92–102. [PubMed: 11115378] 
Megarbane H, Florence J, Oliver Sass J, Schwonbeck S, Foglio M, de Cid R, Cure S, Saker S, 
Megarbane A, Fischer J. An Autosomal-Recessive Form of Cutis Laxa Is Due to Homozygous 
Elastin Mutations, and the Phenotype May Be Modified by a Heterozygous Fibulin 5 
Polymorphism. J Invest Dermatol. 2009; 129:1650–1655. [PubMed: 19194475] 
Brunetti-Pierri et al. Page 5









Morava E, Guillard M, Lefeber DJ, Wevers RA. Autosomal recessive cutis laxa syndrome revisited. 
Eur J Hum Genet. 2009; 17:1099–1110. [PubMed: 19401719] 
Morava E, Zeevaert R, Korsch E, Huijben K, Wopereis S, Matthijs G, Keymolen K, Lefeber DJ, De 
Meirleir L, Wevers RA. A common mutation in the COG7 gene with a consistent phenotype 
including microcephaly, adducted thumbs, growth retardation, VSD and episodes of hyperthermia. 
Eur J Hum Genet. 2007; 15:638–645. [PubMed: 17356545] 
Pandey R, Garg R, Manikandan R, Punj J, Darlong V, Singh SA. Perianesthetic management of 
generalized congenital cutis laxa syndrome associated with pulmonary stenosis undergoing 
inguinal hernia repair. Paediatr Anaesth. 2008; 18:907–909. [PubMed: 18768070] 
Rubin LJ. Primary pulmonary hypertension. N Engl J Med. 1997; 336:111–117. [PubMed: 8988890] 
Szabo Z, Crepeau MW, Mitchell AL, Stephan MJ, Puntel RA, Yin Loke K, Kirk RC, Urban Z. Aortic 
aneurysmal disease and cutis laxa caused by defects in the elastin gene. J Med Genet. 2006; 
43:255–258. [PubMed: 16085695] 
Thomson JR, Machado RD, Pauciulo MW, Morgan NV, Humbert M, Elliott GC, Ward K, Yacoub M, 
Mikhail G, Rogers P, Newman J, Wheeler L, Higenbottam T, Gibbs JS, Egan J, Crozier A, 
Peacock A, Allcock R, Corris P, Loyd JE, Trembath RC, Nichols WC. Sporadic primary 
pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a 
receptor member of the TGF-beta family. J Med Genet. 2000; 37:741–745. [PubMed: 11015450] 
Tsuji A, Yanai J, Miura T, Shirai Y, Osano M, Hosoda Y, Sato M, Asaishi T, Oda Y, Hajikano H. 
Vascular abnormalities in congenital cutis laxa--report of two cases. Acta Paediatr Jpn. 1990; 
32:155–161. [PubMed: 2116064] 
Urban Z, Gao J, Pope FM, Davis EC. Autosomal dominant cutis laxa with severe lung disease: 
synthesis and matrix deposition of mutant tropoelastin. J Invest Dermatol. 2005; 124:1193–1199. 
[PubMed: 15955094] 
Urban Z, Hucthagowder V, Schurmann N, Todorovic V, Zilberberg L, Choi J, Sens C, Brown CW, 
Clark RD, Holland KE, Marble M, Sakai LY, Dabovic B, Rifkin DB, Davis EC. Mutations in 
LTBP4 cause a syndrome of impaired pulmonary, gastrointestinal, genitourinary, musculoskeletal, 
and dermal development. Am J Hum Genet. 2009; 85:593–605. [PubMed: 19836010] 
Weir EK, Joffe HS, Blaufuss AH, Beighton P. Cardiovascular abnormalities in cutis laxa. Eur J 
Cardiol. 1977; 5:255–261. [PubMed: 856600] 
Wu X, Steet RA, Bohorov O, Bakker J, Newell J, Krieger M, Spaapen L, Kornfeld S, Freeze H. 
Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder. Nat Med. 
2004; 10:518–523. [PubMed: 15107842] 
Brunetti-Pierri et al. Page 6










Post-mortem photograph. Note the redundancy of the skin, low-set right ear, hooked nose, 
and the umbilical hernia.
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A. Enlargement of airspaces of the lung (10×). B. Lung tissue with severe proliferation of 
pulmonary-artery smooth muscle (50×).
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Hematoxylin-eosin staining of the skin (100×): intact epidermis and marked reduction in 
elastic fibers in papillary dermis and deep dermis in the patient (A) as compared to a normal 
control (B). Elastic stain of the skin of the patient shows decreased elastin fibers (C) as 
compared to a normal control (D) (200×).
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Electron microscopy of the skin showing elastic fibers fragmentation and increased granular 
substance.
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